ストックスクリーナーアプリを入手
43.69
2.43%
-1.09
アフターアワーズ：
43.69
前日終値:
$44.78
開ける：
$44.43
24時間の取引高:
1.45M
Relative Volume:
0.52
時価総額：
$9.02B
収益：
$2.10B
当期純損益:
$402.17M
株価収益率:
22.57
EPS:
1.9357
ネットキャッシュフロー:
$403.87M
1週間 パフォーマンス:
+2.85%
1か月 パフォーマンス:
-0.86%
6か月 パフォーマンス:
+9.42%
1年 パフォーマンス:
-4.46%
1日の値動き範囲:
$43.62
$44.47
1週間の範囲:
$42.56
$44.82
52週間の値動き範囲:
$32.53
$57.81
Qiagen Nv Stock (QGEN) Company Profile
Compare QGEN vs TMO, DHR, NTRA, A, IQV
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
QGEN
Qiagen Nv
|
43.69 | 8.78B | 2.10B | 402.17M | 403.87M | 1.9357 |
TMO
Thermo Fisher Scientific Inc
|
658.52 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
221.09 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
390.90 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
167.26 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
270.09 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
Qiagen Nv Stock (QGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-14 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2026-03-13 | アップグレード | Deutsche Bank | Hold → Buy |
| 2026-01-22 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2025-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-06-24 | 開始されました | Barclays | Overweight |
| 2025-04-04 | ダウングレード | Redburn Atlantic | Buy → Neutral |
| 2025-02-19 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2025-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2024-12-10 | アップグレード | Jefferies | Hold → Buy |
| 2024-10-17 | ダウングレード | HSBC Securities | Buy → Hold |
| 2024-06-27 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2023-12-19 | 開始されました | Wells Fargo | Equal Weight |
| 2023-12-13 | 開始されました | Wolfe Research | Peer Perform |
| 2023-12-07 | アップグレード | Goldman | Neutral → Buy |
| 2023-09-12 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-23 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-01-18 | アップグレード | DZ Bank | Hold → Buy |
| 2021-10-15 | 再開されました | Cowen | Market Perform |
| 2021-10-14 | 開始されました | Redburn | Buy |
| 2021-07-14 | ダウングレード | Kepler | Buy → Hold |
| 2021-06-03 | 開始されました | Goldman | Neutral |
| 2020-10-06 | 再開されました | BofA Securities | Buy |
| 2020-09-28 | アップグレード | Kepler | Hold → Buy |
| 2020-08-24 | アップグレード | Citigroup | Neutral → Buy |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-08-17 | アップグレード | Berenberg | Hold → Buy |
| 2020-08-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-08-14 | アップグレード | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-04 | ダウングレード | Berenberg | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-12-26 | 再開されました | BofA/Merrill | Underperform |
| 2019-11-15 | 開始されました | Stifel | Hold |
| 2019-11-14 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-11-14 | アップグレード | JP Morgan | Underweight → Overweight |
| 2019-11-14 | アップグレード | Kepler | Reduce → Hold |
| 2019-10-17 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2019-10-09 | ダウングレード | Kepler | Hold → Reduce |
| 2019-10-08 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-10-08 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2019-10-08 | ダウングレード | JP Morgan | Neutral → Underweight |
すべてを表示
Qiagen Nv (QGEN) 最新ニュース
Qiagen stock gains on UBS upgrade and ECPI inclusion - ad-hoc-news.de
36,400 Shares in Qiagen N.V. $QGEN Purchased by WINTON GROUP Ltd - MarketBeat
Qiagen stock gains as UBS upgrade and Q2 2026 figures support outlook - ad-hoc-news.de
Qiagen (NYSE:QGEN) Upgraded at UBS Group - MarketBeat
Qiagen stock holds steady as Berenberg reiterates Neutral rating - ad-hoc-news.de
Qiagen N.V. : Berenberg is Neutral - marketscreener.com
Qiagen stock heads into the open after a 0.28 percent gain - ad-hoc-news.de
Qiagen (NYSE:QGEN): Is This Valuation Mispriced? - Kalkine Media
Qiagen stock edges higher as Bank of America lifts stake and UBS trims target - ad-hoc-news.de
symbol__ Stock Quote Price and Forecast - CNN
Qiagen stock heads into the open after a 0.28% gain - ad-hoc-news.de
Bank of America lifts Qiagen voting rights stake to 5.03% - Bitget
Qiagen grants performance-linked share units to CEO under MAR disclosure - The Globe and Mail
PTA-PVR: QIAGEN N.V.: Release according to Article 40, Section 1 of the WpHG - TradingView
Release according to Article 40, Section 1 of the WpHG - TradingView
QGEN Maintained by UBS -- Price Target Lowered to $47.00 - GuruFocus
Qiagen N.V. Announces Resignation of Thierry Bernard as Member of Managing Board, Effective from September 1, 2026 - marketscreener.com
Qiagen (NYSE:QGEN): Can Its New Launch Unlock Value? - Kalkine Media
UBS Adjusts Price Target on QIAGEN to $47 From $52, Keeps Neutral Rating - marketscreener.com
Qiagen stock holds steady as analysts see limited upside - ad-hoc-news.de
New CEO to lead Qiagen (NYSE: QGEN) as board reviews strategy - Stock Titan
Qiagen N.V. $QGEN Stake Reduced by Allianz Asset Management GmbH - MarketBeat
Qiagen stock heads into the open after a 0.25 percent dip - ad-hoc-news.de
PTA-DD: QIAGEN N.V.: Managers' transactions announcement according to article 19 MAR - TradingView
Managers' transactions announcement according to article 19 MAR - TradingView
Groupe la Francaise Has $3.25 Million Stake in Qiagen N.V. $QGEN - MarketBeat
Qiagen stock heads into the open after a 2.0 percent drop - ad-hoc-news.de
Qiagen stock edges lower as investors look beyond recent earnings - ad-hoc-news.de
Qiagen N.V. (QGEN) Stock Analysis: Exploring The 5.98% Potential Upside For Investors - DirectorsTalk Interviews
New CEO took over the reins - european-biotechnology.com
Qiagen stock heads into the open after a muted move on Xetra - ad-hoc-news.de
Public Employees Retirement System of Ohio Purchases New Shares in Qiagen N.V. $QGEN - MarketBeat
Qiagen (QGEN) Beat Q2 Estimates And Reaffirmed Outlook, Is It Still Below Fair Value? - Yahoo Finance
AFM discloses Goldman Sachs’ 2.91% stake in Qiagen - The Globe and Mail
Qiagen N.V.ADR Key Financial Ratios – Valuation, Profitability & More - Value Research
Qiagen stock trades around 43 dollars as investors watch margins and diagnostics demand - ad-hoc-news.de
Qiagen (QGEN) Up 5.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Global Multiplex Assays Market 2026 Edition - GlobeNewswire Inc.
Qiagen stock holds steady as margins and stake disclosure support valuation - AD HOC NEWS
BlackRock Discloses Significant Stake in Qiagen Under AFM Rules - The Globe and Mail
Qiagen stock holds near 43 dollars as stake disclosure and margins support valuation - AD HOC NEWS
Qiagen stock holds near 43 dollars after steady analyst view - AD HOC NEWS
Qiagen NV at Citi Global Healthcare Conference Transcript - GuruFocus
Qiagen stock steadies near 43 dollars as latest quarter shows modest growth - AD HOC NEWS
Qiagen NV Annual Shareholders Meeting Transcript - GuruFocus
Q3 2025 Qiagen NV Earnings Call Transcript - GuruFocus
Qiagen stock holds mid-40 dollar level as analysts stick to hold ratings - AD HOC NEWS
Plant Virome Diagnostics Outlook 2026-2030 Featuring Profiles of Illumina, Thermo Fisher Scientific and Qiagen - Yahoo Finance
Qiagen N.V. (NYSE:QGEN) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
List of 26 Acquisitions by Qiagen (Sep 2026) - Tracxn
Qiagen stock steadies around $43 as investors digest legal and ownership signals - AD HOC NEWS
Qiagen Nv (QGEN) 財務データ
収益
当期純利益
現金流量
EPS
4.13%
4.22%
大文字化:
|
ボリューム (24 時間):